Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Urilys-Comfort is a dietary supplement developed by Euro Generics (part of the STADA Group) designed to support urinary tract health and comfort. The product contains a combination of three active ingredients: cranberry extract (Exocyan™) standardized to provide at least 36 mg of proanthocyanidins (PACs), goldenrod plant extract (Solidago virgaurea), and vitamin D3. The cranberry PACs are bioflavonoids that help prevent bacteria, such as Escherichia coli, from adhering to the urinary tract epithelium, thereby supporting bladder health. Goldenrod extract is included to contribute to urinary comfort, while vitamin D3 supports the normal function of the immune system. It is formulated as an oral tablet and is indicated for individuals aged 12 and older for the maintenance of a healthy urinary tract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Urilys-Comfort.